(Q35970366)

11 August 2017

1 reference

title

Oral fluid as a diagnostic tool (English)

1 reference

11 August 2017

Robin E Choo

1

1 reference

PubMed ID

15576290

11 August 2017

Marilyn A Huestis

series ordinal

2

1 reference

11 August 2017

1 January 2004

1 reference

Clinical Chemistry and Laboratory Medicine

11 August 2017

1 reference

11 August 2017

42

1 reference

11 August 2017

1273-1287

1 reference

11 August 2017

11

1 reference

The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations

11 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

High sensitivity ELISA determination of taxol in various human biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary cortisol as a tool for physiological studies and diagnostic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

The potential use of saliva to detect recurrence of disease in women with breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Influence of menstrual cycle on the pharmacokinetics of paracetamol through salivary compartment in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary levels of anticonvulsants: A practical approach to drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Review: therapeutic drug monitoring in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Diazepam and N-desmethyldiazepam in saliva of hospital inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary IgA antigliadin antibody as a marker for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary and urinary excretion and plasma-saliva concentration ratios of isoniazid in the presence of Co-administered ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

A comparison between on-site immunoassay drug-testing devices and laboratory results

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Accuracy of oral specimen testing for human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Development and evaluation of an antibody capture ELISA for detection of IgG to Epstein-Barr virus in oral fluid samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Drugs of abuse in saliva: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

The role of saliva in drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Creatinine VIII: Saliva levels of endogenous “true” creatinine in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

A comparison of serum and saliva paracetamol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Biology and disease associations of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Oral absorption and secretion of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Topiramate concentration in saliva: an alternative to serum monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Therapeutic drug monitoring in saliva. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Improved performance 4 hours after cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Correlation of lamotrigine concentrations between serum and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Developmental toxicity of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

The feasibility and acceptability of collecting oral fluid from healthy children for anti-HCV testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Correlation of levetiracetam concentrations between serum and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Sensitivity, Specificity, and Efficiency in Detecting Opiates in Oral Fluid with the Cozart(R) Opiate Microplate EIA and GC-MS Following Controlled Codeine Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Role of salivary IgA in the pathogenesis of Sjögren syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Salivary cortisol levels throughout childhood and adolescence: relation with age, pubertal stage, and weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

Concentrations of Major Elements and Mercury in Unstimulated Human Saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.248

21 January 2018

Identifiers

DOI

10.1515/CCLM.2004.248

1 reference

11 August 2017

1 reference

PubMed ID

15576290